u.s. listing, page-3

Hi Gerry,

http://www.adrbny.com/dr_watchlist.jsp

Latest notice on VCR on that site

Australian 'Artificial Heart' Patient Update
6:13 AM ET Aug 20, 2003
SYDNEY, Australia, Aug 20, 2003 /PRNewswire-FirstCall via COMTEX/ -- Medical investigators in Australia today provided a progress report on the clinical trial of Ventracor's (OTC: VTCRY; ASX: VCR) left ventricular assist system (LVAS) at The Alfred hospital in Melbourne.

The VentrAssist (TM) is a third generation LVAS with a unique design which features only one moving part, a hydrodynamically suspended impeller.

The patient who received the first implant of the VentrAssist(TM) on 28 June 2003 was discharged home from hospital late yesterday (19 August).

Chief Medical Investigator, Professor Don Esmore said: "The first patient implanted with the VentrAssist(TM) has made an excellent early recovery."

"When the patient entered hospital in June he was gravely ill with a 13-year history of progressive heart disease.

"While ongoing monitoring of the patient will be required as with a heart transplant patient, the quality of life for this patient has been substantially enhanced.

"The Alfred medical team is very keen to proceed with the next implant," Professor Esmore said.

The Pilot Trial evaluates the safety of the VentrAssist(TM) LVAS in up to 10 patients suffering end-stage congestive heart failure. The trial results will be based on outcomes from all patients. While individual outcomes are very important, it is the accumulation of all data on the safety of the device that will decide the outcome of the trial.

The VentrAssist(TM) LVAS provides left heart support and is designed as a permanent alternative to a heart transplant. The titanium alloy pump is implanted below the diaphragm and is connected to the circulatory system using standard fabric tubes known as vascular grafts. The device itself is 2.5 inches (60 mm) in diameter and weighs just 10oz (298 grams). This allows it to be used in both children and adults.

An estimated 11 million people suffer from congestive heart failure with only 3,000 heart transplants performed worldwide each year.

SOURCE Ventracor Limited

Ventracor Limited, +61-2-94063100, or [email protected]
http://www.ventracor.com
Copyright (C) 2003 PR Newswire. All rights reserved.

Cheers,

Fig Jam